Back to Results
First PageMeta Content
Calcitonin gene-related peptide / Peptide hormones / Calcitonin / Drug discovery / Pharmaceutical sciences / Pharmacology / Medicinal chemistry


News Release FOR  IMMEDIATE  RELEASE Contact:  Ronald C. Trahan, APR, Ronald Trahan Associates Inc., ([removed], x108 VasoGenix Pharmaceuticals selects a lead CGRP (calcitonin gene-related peptide) agonist anal
Add to Reading List

Document Date: 2009-04-13 11:54:06

Open Document

File Size: 139,33 KB

Share Result on Facebook

City

Kansas City / /

Company

VasoGenix Pharmaceuticals Inc. / Ronald Trahan Associates Inc. / /

Event

FDA Phase / Judicial Event / /

IndustryTerm

treatment for heart failure / biopharmaceutical / similar receptor site / a heart failure treatment / treatment of heart failure / /

MedicalCondition

nation’s most expensive disease / heart failure / inflammation / /

OperatingSystem

AROs / /

Organization

Food and Drug Administration / /

Person

G. Lee Southard / Jeff Southard / /

/

Position

Private / Chairman and CEO / Vice President Drug Development / candidate / /

Product

Jeff Southard / /

ProvinceOrState

Kansas / /

Technology

Drug Development / /

URL

www.vasogenix.net / /

SocialTag